Molecular Pituitary Imaging Using 18F-FET PET

Recruiting now · Not applicable

Conditions studied: Pituitary Adenoma

In brief

The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.

Key facts

Study ID

NCT06584123

Run by

University of Cambridge

People needed

20

Starts

2024-09-03

Expected to finish

2026-12-31

Last updated by the study team

2026-01-06

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant is willing and able to give informed consent for participation in the study
• Male or female, age 18 or above
• Presence of pituitary adenoma suspected on the basis of clinical/biochemical and/or radiological findings
• Previous 11C-Met-PET/CT

You may not qualify if…

• Inability to give informed consent
• Pregnancy or suspected pregnancy
• Inability to lie supine for 30-60 minutes
• Patient body habitus above scanner dimensions
• Known allergy to intravenous radiographic contrast agents

Where it is running

• Cambridge University Hospitals — Cambridge, Cambridgeshire, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.